News for Providers
Top stories summarized by our editors
2/20/2019

Dr. Priscilla Chan, who with husband Mark Zuckerberg launched the Chan Zuckerberg Initiative in 2015 to tackle global health problems and cure disease, called the project an accelerator that allows researchers to think through difficult problems. Chan says they are empowering scientists to come up with discoveries on the scale of the development of penicillin, the microscope and DNA sequencing.

Full Story:
CBS News
2/20/2019

Care procedures for infants with neonatal abstinence syndrome are changing, with increased use of non-pharmacological treatments such as dim lighting and an emphasis on interacting with mothers non-judgmentally, neonatologist Kristina Reber writes. Reber says she and her team at Nationwide Children's Hospital in Columbus, Ohio, make social work consultations a part of the new family's treatment plan.

2/20/2019

Encourage ideas from your team by thanking them each time for their input, as well as keeping them updated on progress and the timeline, writes David Dye. Employees should receive an explanation when suggestions aren't workable and celebrated when ideas result in solutions, Dye notes.

Full Story:
Let's Grow Leaders
More Summaries:
David Dye
2/20/2019

Patients with type 1 diabetes on SGLT inhibitor therapy are advised to follow regular diets, consume only a small amount of alcohol, adhere to prescribed treatment protocols and should have normal ketone levels to reduce their risk for diabetic ketoacidosis, according to a consensus report from the International Conference of Advanced Technologies & Treatments for Diabetes Congress that was published in Diabetes Care. Clinicians are also recommended to administer the SGLT inhibitor therapy at the lowest dose possible when patients' blood ketone levels are less than 0.6 mmol/L and to adjust and monitor insulin doses based on individual patient level.

Full Story:
Endocrinology Advisor
2/20/2019

A study in The Journal of Clinical Endocrinology & Metabolism showed that there was a -1.05% drop in insulin resistance and a -0.54% improvement in beta-cell function for every additional 1-hour increase in bright sunlight exposure during the seven days before individuals provided their fasting blood samples, which may be associated with a reduced type 2 diabetes risk. UK researchers analyzed data on 10,226 middle-aged adults without diabetes and found that glucose and lipid metabolism were also associated with bright sunlight exposure in one cohort, but with smaller effect sizes.

2/20/2019

Researchers used a cohort of 913 women with gestational diabetes mellitus and found no significant differences in the incidence of the primary outcome, including pregnancy-induced hypertension, macrosomia, cesarean section delivery and neonatal hypoglycemia, between those who underwent early screening at 14 to 20 weeks of gestation and those who had routine screening. The findings were presented at the Society for Maternal-Fetal Medicine's annual meeting.

2/20/2019

Some large pharmaceutical companies have backed away from antibiotic development, leaving the market for smaller companies, including Entasis Therapeutics. CEO Manos Perros said the future of antibiotic development will be focused on premium-priced drugs that target treatment-resistant pathogens for the small sector of patients who do not respond to less-expensive generics.

More Summaries:
Entasis Therapeutics
2/20/2019

Epic Systems CEO Judy Faulkner says health system leaders are committed to moving to value-based care, talking about it as a better way to treat patients and not as a financial strategy. Faulkner said four near-term goals for tech include using big data analytics to support evidence-based medicine, developing digital prior preauthorizations, creating a comprehensive EHR and bringing socioeconomic data to the care process.

Full Story:
Health IT Analytics
More Summaries:
Judy Faulkner, Epic Systems
2/20/2019

A survey of more than 220 health care executives showed 74% said significant health care policy changes are very likely or somewhat likely over the next two years in areas such as drug prices, value-based care and state Medicaid programs. Forty-one percent said universal health coverage is important, but they were skeptical the US would move toward that model within the next 10 years.

Full Story:
FierceHealthcare
2/20/2019

We should encourage and inspire patients and families to make the decision to opt-in and share their data with trusted research organizations and foundations, writes Backpack Health CEO James Cavan. By overcoming traditional research barriers, and empowering patients and families to contribute their data, they can have a growing influence on setting the research agenda and advancing scientific knowledge in delivering the best possible care and outcomes, Cavan writes.

Full Story:
MedCity News
More Summaries:
Backpack Health